Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
株式のランク #4732
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
株価
$48.46
時価総額
$3.35B
変化(1日)
-1.09%
変化(1年)
186.60%
US
取引 Pulse Biosciences, Inc. (PLSE)

カテゴリー

Pulse Biosciences, Inc.(PLSE)の配当利回りの履歴
Pulse Biosciences, Inc.(銘柄コード: PLSE)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Pulse Biosciences, Inc.(PLSE)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)